Cychlorphine, opioid analog, presents new threat
Alcoholism & Drug Abuse Weekly · 02.11.2026 · 38 (42) · 6-8
DOI: 10.1002/adaw.35099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcoholism & Drug Abuse Weekly, online erschienen am 30.10.2026. Verfasst von Alison Knopf.
Abstract (Originalsprache)
Cychlorphine is a synthetic opioid which presents a new threat to public health. In the Journal of Pain Research , a study published in July highlights the lethality of a recent wave of nitazenes. First synthesized in the 1950s but never approved for medical use, these potent 2‐benzylbenzimidazole opioids have seen a sharp rise in analogs after scheduling by the Chinese government in July 2025. Nitazenes went down, but the analogs went up.
Zitieren
APA
Knopf, A. (2026). Cychlorphine, opioid analog, presents new threat. Alcoholism & Drug Abuse Weekly, 38(42), 6-8. https://doi.org/10.1002/adaw.35099
Vancouver
Knopf A. Cychlorphine, opioid analog, presents new threat. Alcoholism & Drug Abuse Weekly. 2026;38(42):6-8. doi:10.1002/adaw.35099
BibTeX
@article{Knopf2026,
author = {Knopf, Alison},
title = {Cychlorphine, opioid analog, presents new threat},
journal = {Alcoholism & Drug Abuse Weekly},
year = {2026},
volume = {38},
number = {42},
pages = {6--8},
doi = {10.1002/adaw.35099}
}
EUVIMED